Bajaj Finserv Healthcare Fund
Direct · Growth ₹11.58
21 Jul 2026
NAV
7.6%
Weighted CAGR
?
Weighted Mean CAGR
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
0.18
Sharpe
-15.7%
Max Drawdown
?
Max Drawdown
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
NA
TER
If you invested ₹1,00,000 every month via SIP, here's how this fund has historically performed across different time horizons.
| Duration | Invested | Median Value | XIRR | Min XIRR | Max XIRR |
|---|---|---|---|---|---|
| 1 Year | ₹12.00 L | ₹12.36 L | 7.9% | -11.5% | 33.4% |
SIP returns vs benchmark & category
Annualised SIP return (XIRR) over each rolling horizon — like-for-like, not lump-sum.
| Duration | Fund SIP XIRR | NIFTY 50 | Category avg | Fund edge |
|---|---|---|---|---|
| 1 Year | 7.9% | 14.5% | 13.7% | -6.6% |
| Duration | Mean | Median | Min | Max | Sharpe | Sortino | % Positive | Cat. Mean | Cat. Median |
|---|---|---|---|---|---|---|---|---|---|
| 1 Year | 7.6% | 8.6% | -4.2% | 16.7% | 0.18 | 0.28 | 83% | — | — |
-15.7%
Max Drawdown
2 mo
Drawdown Duration
9 mo
Recovery Time
-4.6%
Avg Drawdown
Calmar Ratio by Duration
0.48
1Y
Compared against NIFTY 50
| Duration | Alpha | Beta | Upside Capture | Downside Capture | Fund CAGR | Bench CAGR |
|---|---|---|---|---|---|---|
| 1 Year | +14.92 | 0.59 | 73.6% | 52.1% | 15.6% | -3.4% |
| 3 Years | +1.61 | 0.64 | 72.9% | 62.8% | 4.5% | 0.8% |
| 5 Years | -0.01 | 0.64 | 72.9% | 62.8% | 2.7% | 0.5% |
| 7 Years | -0.68 | 0.64 | 72.9% | 62.8% | 1.9% | 0.3% |
| 10 Years | -1.19 | 0.64 | 72.9% | 62.8% | 1.3% | 0.3% |
| 12 Years | -1.39 | 0.64 | 72.9% | 62.8% | 1.1% | 0.2% |
| 15 Years | -1.59 | 0.64 | 72.9% | 62.8% | 0.9% | 0.2% |
31
Total Holdings
53.9%
Top 10 Weight
8
Sectors
| # | Stock | % of NAV |
|---|---|---|
| 1 | Divi's Laboratories Limited | 9.07% |
| 2 | Apollo Hospitals Enterprise Limited | 6.73% |
| 3 | Sun Pharmaceutical Industries Limited | 6.54% |
| 4 | Aurobindo Pharma Limited | 6.17% |
| 5 | Torrent Pharmaceuticals Limited | 5.26% |
| 6 | Rubicon Research Limited | 4.52% |
| 7 | Neuland Laboratories Limited | 4.39% |
| 8 | Emcure Pharmaceuticals Limited | 4.18% |
| 9 | Max Healthcare Institute Limited | 3.68% |
| 10 | Fortis Healthcare Limited | 3.36% |